BioGenerics 2008
from Miscellaneous Group
This event has passed.
Sunday, March 2, 2008, 4:00pm - 7:00pm
An open forum on the scientific and regulatory issues behind biogenerics. Discuss leading policy questions with global thought leaders in an open, non-partisan forum.
By the year 2010, $20 billion worth of protein pharmaceuticals will be off patent and in a market open to generic manufacturers. Subtle changes, such as in glycosylation or formulation, may show dramatic effects, or no effect, on efficacy and safety.
What analytical or clinical validation should be required of biogenerics (biosimilars or follow-on biologics)? What metrics can be developed and validated to detect variation, determine its significance, and to monitor quality? How should we weigh uncertainty in risk against the public health benefits of reducing drug costs?
More information...
Pingbacks ( Use this URL to link to this event: http://www.marksguide.com/event/1354/ )
